Three biotechnical processes using Ashbya gossypii, Candida famata, or Bacillus subtilis compete with chemical riboflavin production (original) (raw)

Abstract

Chemical riboflavin production, successfully used for decades, is in the course of being replaced by microbial processes. These promise to save half the costs, reduce waste and energy requirements, and use renewable resources like sugar or plant oil. Three microorganisms are currently in use for industrial riboflavin production. The hemiascomycetes Ashbya gossypii, a filamentous fungus, and Candida famata, a yeast, are naturally occurring overproducers of this vitamin. To obtain riboflavin production with the Gram-positive bacterium Bacillus subtilis requires at least the deregulation of purine synthesis and a mutation in a flavokinase/FAD-synthetase. It is common to all three organisms that riboflavin production is recognizable by the yellow color of the colonies. This is an important tool for the screening of improved mutants. Antimetabolites like itaconate, which inhibits the isocitrate lyase in A. gossypii, tubercidin, which inhibits purine biosynthesis in C. famata, or roseoflavin, a structural analog of riboflavin used for B. subtilis, have been applied successfully for mutant selections. The production of riboflavin by the two fungi seems to be limited by precursor supply, as was concluded from feeding and gene-overexpression experiments. Although flux studies in B. subtilis revealed an increase both in maintenance metabolism and in the oxidative part of the pentose phosphate pathway, the major limitation there seems to be the riboflavin pathway. Multiple copies of the rib genes and promoter replacements are necessary to achieve competitive productivity.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Institut für Biotechnologie 1, Forschungszentrum Jülich, 52425 Jülich, Germany e-mail: P.Stahmann@fz-juelich.de Tel.: +49-2461-612843/5446 Fax: +49-2461-612710, , , , , , DE
    K. -P. Stahmann
  2. Departamento de Microbiologia y Genetica, Universidad de Salamanca, Campus Miguel de Unamuno, 37007 Salamanca, Spain, , , , , , ES
    J. L. Revuelta
  3. SunGene, Corrensstrasse 3, 06466 Gatersleben, Germany, , , , , , DE
    H. Seulberger

Authors

  1. K. -P. Stahmann
    You can also search for this author inPubMed Google Scholar
  2. J. L. Revuelta
    You can also search for this author inPubMed Google Scholar
  3. H. Seulberger
    You can also search for this author inPubMed Google Scholar

Additional information

Received: 19 November 1999 / Accepted: 21 December 1999

Rights and permissions

About this article

Cite this article

Stahmann, KP., Revuelta, J. & Seulberger, H. Three biotechnical processes using Ashbya gossypii, Candida famata, or Bacillus subtilis compete with chemical riboflavin production.Appl Microbiol Biotechnol 53, 509–516 (2000). https://doi.org/10.1007/s002530051649

Download citation

Keywords